Tabitha Tombe
Publications by Year
Research Areas
Axon Guidance and Neuronal Signaling, RNA modifications and cancer, Apelin-related biomedical research, Angiogenesis and VEGF in Cancer, Prostate Cancer Treatment and Research
Most-Cited Works
- → SEMA 3C drives cancer growth by transactivating multiple receptor tyrosine kinases via Plexin B1(2018)96 cited
- → Semaphorin 3 C drives epithelial-to-mesenchymal transition, invasiveness, and stem-like characteristics in prostate cells(2017)54 cited
- → Ubiquitous expression of the monomeric red fluorescent protein mcherry in transgenic mice(2010)40 cited
- → Suppression of LIM and SH3 Domain Protein 1 (LASP1) Negatively Regulated by Androgen Receptor Delays Castration Resistant Prostate Cancer Progression(2016)15 cited
- → Targeting Semaphorin 3C in Prostate Cancer With Small Molecules(2018)14 cited
- → CXCR4-LASP1-G9a-SNAIL axis drives NEPC transdifferentiation via induction of EMT and downregulation of REST(2025)4 cited
- → Semaphorin 3C promotes de novo steroidogenesis in prostate cancer cells(2023)3 cited
- → MP39-17 A NOVEL COMBINATORIAL THERAPY IN RENAL CELL CARCINOMA: SILENCING SEMAPHORIN 3C IN COMBINATION WITH SUNITINIB(2015)
- → MP66-02 INHIBITION OF LIM-SH3 DOMAIN PROTEIN1 AUGMENTS THE ANTI-CANCER EFFECT OF ENZALUTAMIDE IN PROSTATE CANCER.(2015)
- → A mouse model of bladder-specific over-expression of NOTCH2 confirms the oncogenic role of NOTCH2 in bladder cancer(2017)